0001179110-13-015577.txt : 20131016
0001179110-13-015577.hdr.sgml : 20131016
20131016193506
ACCESSION NUMBER: 0001179110-13-015577
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131011
FILED AS OF DATE: 20131016
DATE AS OF CHANGE: 20131016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Astex Pharmaceuticals, Inc
CENTRAL INDEX KEY: 0000919722
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 911841574
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4140 DUBLIN BLVD
STREET 2: SUITE 200
CITY: DUBLIN
STATE: CA
ZIP: 94568
BUSINESS PHONE: 9255600100
MAIL ADDRESS:
STREET 1: 4140 DUBLIN BLVD
STREET 2: STE 200
CITY: DUBLIN
STATE: CA
ZIP: 94568
FORMER COMPANY:
FORMER CONFORMED NAME: SUPERGEN INC
DATE OF NAME CHANGE: 19960125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LACK WALTER J
CENTRAL INDEX KEY: 0001207708
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-27628
FILM NUMBER: 131155050
4
1
edgar.xml
FORM 4 -
X0306
4
2013-10-11
1
0000919722
Astex Pharmaceuticals, Inc
ASTX
0001207708
LACK WALTER J
C/O ENGSTROM LIPSCOMB & LACK
10100 SANTA MONICA BLVD., 12TH FLOOR
LOS ANGELES
CA
90067-4113
1
0
0
0
Common Stock
2013-10-11
4
U
0
457500
D
0
D
Director Stock Option (Right to buy)
7.79
2013-10-11
4
D
0
22500
D
2014-05-06
Common Stock
22500
0
D
Director Stock Option (Right to buy)
5.89
2013-10-11
4
D
0
30000
D
2017-06-14
Common Stock
30000
0
D
Director Stock Option (Right to buy)
2.10
2013-10-11
4
D
0
45000
D
2022-06-22
Common Stock
45000
0
D
Director Stock Option (Right to buy)
4.60
2013-10-11
4
D
0
45000
D
2023-06-13
Common Stock
45000
0
D
Pursuant to the Agreement and Plan of Merger, dated September 5, 2013, between the Issuer, Otsuka Pharmaceutical Co. Ltd., and Autumn Aquisition Corporation (the "Merger Agreement"), each share of Common Stock was exchanged for $8.50 in cash.
The option provided for vesting as to 1/4th of the shares on May 6, 2004 and on each three month anniversary thereafter.
Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $15,975.00, which represents the difference between $8.50 and the exercise price of the option per share.
The option provided for vesting as to 1/4th of the shares on June 14, 2007 and on each three month anniversary thereafter.
Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $78,300.00, which represents the difference between $8.50 and the exercise price of the option per share.
The option provided for vesting as to 1/4th of the shares on June 22, 2012 and on each three month anniversary thereafter.
Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $288,000.00, which represents the difference between $8.50 and the exercise price of the option per share.
The option originally provided for vesting as to 1/4th of the shares on June 13, 2013 and on each three month anniversary thereafter. Pursuant to the Merger Agreement, the option vested in full immediately prior to the closing of the merger.
Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $175,500.00, which represents the difference between $8.50 and the exercise price of the option per share.
/s/ Walter J. Lack
2013-10-16